DFINE Clinical Resources
DFINE is committed to building scientific evidence to support the use of our products. To date, DFINE has presented numerous studies at scientific meetings worldwide to illuminate the advantages of radiofrequency (RF) tumor ablation therapy with the STAR™ Tumor Ablation System. Moving forward the company continues to invest in clinical studies to further improve the quality of life for patients suffering from vertebral pathologies complicated by metastatic spinal tumors.
- Bartels R, van der Linden Y, and van der Graaf W. “Spinal Extradural Metastasis: Review of Current Treatment Options.” CA Cancer J Clin. 2008;58:245-259.
- Dupuy DE, Dawei L, Hartfeil D, Hanna L, Blume JD, Ahrar K, Lopez R, Safran H and DiPetrillo T. “Percutaneous Radiofrequency Ablation of Painful Osseous Metastases.” Cancer. 2009; 116(4):989-997.
- Kurup AN and Callstrom MR. “Ablation of skeletal metastases: Current status.” J VascInterv Radiol. 2010;21:S242-S250.
Physicians' insights on RF Ablation
STAR Tumor Ablation Procedure